Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Developing neoantigen-targeted T cell–based treatments for solid tumors

1 Oct 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immune Cell Function and Interaction
Share to Immunotherapy and Immune Responses

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 31591590
DOI: 10.1038/s41591-019-0596-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Developing neoantigen-targeted T cell–based treatments for solid tumorsPMID 31591590Read ↗

Identification of neoantigens for individualized therapeutic cancer vaccinesSemantic proximity Read ↗

Progress in Neoantigen Targeted Cancer ImmunotherapiesSemantic proximity Read ↗

Harnessing neoantigen specific CD4 T cells for cancer immunotherapySemantic proximity Read ↗

Advances in personalized neoantigen vaccines for cancer immunotherapy.Semantic proximity Read ↗

Targeting neoantigens for cancer immunotherapy: Table 1.Semantic proximity Read ↗

Individualised neoantigen cancer vaccine therapy.Semantic proximity Read ↗

Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapiesSemantic proximity Read ↗

Boosting Antitumor Immunity with an Expanded Neoepitope Landscape.Semantic proximity Read ↗

Neoantigens: The Novel Precision Cancer ImmunotherapySemantic proximity Read ↗

Emerging Strategies in TCR-Engineered T CellsSemantic proximity Read ↗

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.Semantic proximity Read ↗

Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.